Debora Capelli

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 215 citations · Full text

Medicine, Internal Medicine, Oncology +8

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · PubMed · 2006 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +17

Fungal infections of the central nervous system and paranasal sinuses in onco‐haematologic patients. Epidemiological study reporting the diagnostic‐therapeutic approach and outcome in 89 cases

Anna Candoni, Alessandro Busca, Roberta Di Blasi et al. · Mycoses · 2018 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +14

The Kinetics and Extent of Engraftment of Chronic Myelogenous Leukemia Cells in Non-Obese Diabetic/Severe Combined Immunodeficiency Mice Reflect the Phase of the Donor’s Disease: An In Vivo Model of Chronic Myelogenous Leukemia Biology

Francesco Dazzi, Debora Capelli, Robert P. Hasserjian et al. · Blood · 1998 · 69 citations

Life Sciences, Hematology, Immunology +12

Amifostine can reduce mucosal damage after high‐dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study

Debora Capelli, Gino Santini, Cármino Antônio De Souza et al. · British Journal of Haematology · 2000 · 58 citations

Pharmacy, Oncology, Pharmacology +16